Response: Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study (Diabetes Metab J 2019;43:640–8)

Detalles Bibliográficos
Autores principales: Chung, Yoo-Ri, Ha, Kyoung Hwa, Lee, Kihwang, Kim, Dae Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2019
Materias:
Response
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943258/
https://www.ncbi.nlm.nih.gov/pubmed/31902152
http://dx.doi.org/10.4093/dmj.2019.0216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943258/
https://www.ncbi.nlm.nih.gov/pubmed/31902152
http://dx.doi.org/10.4093/dmj.2019.0216

Ejemplares similares